A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01554696
Recruitment Status : Completed
First Posted : March 15, 2012
Last Update Posted : December 16, 2014
Information provided by (Responsible Party):
Astellas Pharma Inc

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2014
  Study Completion Date : February 2014
  Certification/Extension First Submitted : December 1, 2014